Our background

• We are a clinical stage spin-off from the Swiss PSI (Center for Radiopharmaceutical Sciences) around
  assets developed jointly with University Hospital Basel.
  
  
• Founded in 2024 by the inventor Martin Behe, the PSI and experienced biopharma entrepreneur Klaus May
  
  
• Patents have been filed in the years 2018-2021 and 2024
  
  
• In collaborations with several leading research hospitals in the field we are ready to enter clinical phase II including University Hospital Basel and the Paul-Scherrer-Institute, Villigen, both Switzerland.